164 related articles for article (PubMed ID: 18029074)
1. Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats.
Egashira N; Ishigami N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):499-506. PubMed ID: 18029074
[TBL] [Abstract][Full Text] [Related]
2. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze.
Mishima K; Egashira N; Matsumoto Y; Iwasaki K; Fujiwara M
Life Sci; 2002 Dec; 72(4-5):397-407. PubMed ID: 12467880
[TBL] [Abstract][Full Text] [Related]
3. Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats.
Egashira N; Manome N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Psychopharmacology (Berl); 2012 Feb; 219(4):1111-8. PubMed ID: 21858449
[TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments.
Zhang C; Fang Y; Xu L
Schizophr Res; 2014 Nov; 159(2-3):376-84. PubMed ID: 25219486
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Mishima K; Egashira N; Hirosawa N; Fujii M; Matsumoto Y; Iwasaki K; Fujiwara M
Jpn J Pharmacol; 2001 Dec; 87(4):297-308. PubMed ID: 11829149
[TBL] [Abstract][Full Text] [Related]
6. The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats.
Inui K; Egashira N; Mishima K; Yano A; Matsumoto Y; Hasebe N; Abe K; Hayakawa K; Ikeda T; Iwasaki K; Fujiwara M
Neurotox Res; 2004; 6(2):153-8. PubMed ID: 15325968
[TBL] [Abstract][Full Text] [Related]
7. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Shirazi-Southall S; Rodriguez DE; Nomikos GG
Neuropsychopharmacology; 2002 May; 26(5):583-94. PubMed ID: 11927183
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats.
Young JM; McGregor IS; Mallet PE
Neuropsychopharmacology; 2005 Aug; 30(8):1475-82. PubMed ID: 16178074
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
Rodrigues LC; Conti CL; Nakamura-Palacios EM
Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
Nava F; Carta G; Colombo G; Gessa GL
Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.
Hou Y; Wu CF; Yang JY; Guo T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1486-95. PubMed ID: 16842896
[TBL] [Abstract][Full Text] [Related]
12. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
Ortega-Alvaro A; Gibert-Rahola J; Micó JA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364
[TBL] [Abstract][Full Text] [Related]
13. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.
Rubino T; Realini N; Braida D; Guidi S; Capurro V; Viganò D; Guidali C; Pinter M; Sala M; Bartesaghi R; Parolaro D
Hippocampus; 2009 Aug; 19(8):763-72. PubMed ID: 19156848
[TBL] [Abstract][Full Text] [Related]
14. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol.
Nagai T; Takuma K; Dohniwa M; Ibi D; Mizoguchi H; Kamei H; Nabeshima T; Yamada K
Psychopharmacology (Berl); 2007 Sep; 194(1):21-32. PubMed ID: 17514479
[TBL] [Abstract][Full Text] [Related]
15. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
D'Souza DC; Braley G; Blaise R; Vendetti M; Oliver S; Pittman B; Ranganathan M; Bhakta S; Zimolo Z; Cooper T; Perry E
Psychopharmacology (Berl); 2008 Jul; 198(4):587-603. PubMed ID: 18228005
[TBL] [Abstract][Full Text] [Related]
16. The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats.
Mishima K; Iwasaki K; Tsukikawa H; Matsumoto Y; Egashira N; Abe K; Egawa T; Fujiwara M
Jpn J Pharmacol; 2000 Oct; 84(2):163-73. PubMed ID: 11128039
[TBL] [Abstract][Full Text] [Related]
17. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.
Egashira N; Matsumoto Y; Mishima K; Iwasaki K; Fujioka M; Matsushita M; Shoyama Y; Nishimura R; Fujiwara M
Pharmacol Biochem Behav; 2006 Jan; 83(1):161-7. PubMed ID: 16492387
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.
Onaolapo OJ; Paul TB; Onaolapo AY
Metab Brain Dis; 2017 Oct; 32(5):1475-1489. PubMed ID: 28508340
[TBL] [Abstract][Full Text] [Related]
19. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.
Fujiwara M; Egashira N
J Pharmacol Sci; 2004 Dec; 96(4):362-6. PubMed ID: 15599103
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M
Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
